Search Results - "Massberg, S."

Crossroads of coagulation and innate immunity: the case of deep vein thrombosis by Schulz, C., Engelmann, B., Massberg, S.

“…Summary Deep vein thrombosis (DVT) is a common condition characterized by the formation of an occlusive blood clot in the venous vascular system, potentially…”
Get full text

Yolk sac macrophage progenitors traffic to the embryo during defined stages of development by Stremmel, C., Schuchert, R., Wagner, F., Thaler, R., Weinberger, T., Pick, R., Mass, E., Ishikawa-Ankerhold, H. C., Margraf, A., Hutter, S., Vagnozzi, R., Klapproth, S., Frampton, J., Yona, S., Scheiermann, C., Molkentin, J. D., Jeschke, U., Moser, M., Sperandio, M., Massberg, S., Geissmann, F., Schulz, C.

“…Tissue macrophages in many adult organs originate from yolk sac (YS) progenitors, which invade the developing embryo and persist by means of local…”
Get full text

Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized trials by STEFANINI, Giulio G, BYRNE, Robert A, SERRUYS, Patrick W, DE WAHA, Antoinette, MEIER, Bernhard, MASSBERG, Steffen, JÜNI, Peter, SCHÖMIG, Albert, WINDECKER, Stephan, KASTRATI, Adnan

“…The efficacy of durable polymer drug-eluting stents (DES) is delivered at the expense of delayed healing of the stented vessel. Biodegradable polymer DES aim…”
Get full text

Stent thrombosis after drug-eluting stent implantation: incidence, timing, and relation to discontinuation of clopidogrel therapy over a 4-year period by Schulz, Stefanie, Schuster, Tibor, Mehilli, Julinda, Byrne, Robert A., Ellert, Julia, Massberg, Steffen, Goedel, Julia, Bruskina, Olga, Ulm, Kurt, Schömig, Albert, Kastrati, Adnan

“…Aims To assess the incidence, timing, and relation of drug-eluting stent (DES) thrombosis to discontinuation of clopidogrel therapy. Methods and results This…”
Get full text

Prasugrel plus bivalirudin vs. clopidogrel plus heparin in patients with ST-segment elevation myocardial infarction by Schulz, Stefanie, Richardt, Gert, Laugwitz, Karl-Ludwig, Morath, Tanja, Neudecker, Julia, Hoppmann, Petra, Mehran, Roxana, Gershlick, Anthony H, Tölg, Ralph, Anette Fiedler, K, Abdel-Wahab, Mohamed, Kufner, Sebastian, Schneider, Simon, Schunkert, Heribert, Ibrahim, Tareq, Mehilli, Julinda, Kastrati, Adnan

“…Whether prasugrel plus bivalirudin is a superior strategy to unfractionated heparin plus clopidogrel in patients with ST-segment elevation myocardial…”
Get full text

Coronary plaque volume and predictors for fast plaque progression assessed by serial coronary CT angiography—A single-center observational study by Weber, C., Deseive, S., Brim, G., Stocker, T.J., Broersen, A., Kitslaar, P., Martinoff, S., Massberg, S., Hadamitzky, M., Hausleiter, J.

“…•Within 3.5 years, progress of coronary plaque volume was found in 223 patients (64 %).•On average, coronary artery plaque volume progressed by 20 % among the…”
Get full text

Author Correction: Yolk sac macrophage progenitors traffic to the embryo during defined stages of development by Stremmel, C., Schuchert, R., Wagner, F., Thaler, R., Weinberger, T., Pick, R., Mass, E., Ishikawa-Ankerhold, H. C., Margraf, A., Hutter, S., Vagnozzi, R., Klapproth, S., Frampton, J., Yona, S., Scheiermann, C., Molkentin, J. D., Jeschke, U., Moser, M., Sperandio, M., Massberg, S., Geissmann, F., Schulz, C.

“…This article contains errors in Figs. 5 and 6, for which we apologize. In Fig. 5f, the image ‘E12.5 tail’ was inadvertently replaced with a duplicate of the…”
Get full text

EMMPRIN (CD147/basigin) mediates platelet–monocyte interactions in vivo and augments monocyte recruitment to the vascular wall by SCHULZ, C., VON BRÜHL, M.‐L., BAROCKE, V., CULLEN, P., MAYER, K., OKROJEK, R., STEINHART, A., AHMAD, Z., KREMMER, E., NIESWANDT, B., FRAMPTON, J., MASSBERG, S., SCHMIDT, R.

“…Background: Platelets play a central role in hemostasis, in inflammatory diseases such as atherosclerosis, and during thrombus formation following vascular…”
Get full text

Strengths and weaknesses of a new mouse model of thrombosis induced by inferior vena cava stenosis: communication from the SSC of the ISTH by Geddings, J., Aleman, M. M., Wolberg, A., Brühl, M.‐L., Massberg, S., Mackman, N.

Get full text

Randomised trial of three rapamycin-eluting stents with different coating strategies for the reduction of coronary restenosis: 2-year follow-up results by Byrne, R A, Kufner, S, Tiroch, K, Massberg, S, Laugwitz, K-L, Birkmeier, A, Schulz, S, Mehilli, J

“…Drug-eluting stent (DES) platforms devoid of durable polymer have potential to enhance long-term safety outcomes. The ISAR-TEST-3 study was a randomised trial…”
Get more information

Contrast-induced acute kidney injury after computed tomography prior to transcatheter aortic valve implantation by Jochheim, D, Schneider, V.-S, Schwarz, F, Kupatt, C, Lange, P, Reiser, M, Massberg, S, Gutiérrez-Chico, J.-L, Mehilli, J, Becker, H.-C

“…Aim To identify independent predictors of contrast medium-induced acute kidney injury (CI-AKI) after enhanced multidetector-row computed tomography (MDCT)…”
Get full text

Inducible disruption of the c-myb gene allows allogeneic bone marrow transplantation without irradiation by Stremmel, C., Schuchert, R., Schneider, V., Weinberger, T., Thaler, R., Messerer, D., Helmer, S., Geissmann, F., Frampton, J., Massberg, S., Schulz, C.

“…Allogeneic bone marrow (BM) transplantation enables the in vivo functional assessment of hematopoietic cells. As pre-conditioning, ionizing radiation is…”
Get full text

ISAR-REACT 3A: a study of reduced dose of unfractionated heparin in biomarker negative patients undergoing percutaneous coronary intervention by Schulz, Stefanie, Mehilli, Julinda, Neumann, Franz-Josef, Schuster, Tibor, Massberg, Steffen, Valina, Christian, Seyfarth, Melchior, Pache, Jürgen, Laugwitz, Karl-Ludwig, Büttner, Hans-Joachim, Ndrepepa, Gjin, Schömig, Albert, Kastrati, Adnan

“…Aims Although a 140 U/kg dose of unfractionated heparin (UFH) was comparable with bivalirudin in terms of net clinical outcome in the Intracoronary Stenting…”
Get full text

Quantification of coronary low-attenuation plaque volume for long-term prediction of cardiac events and reclassification of patients by Deseive, S., Straub, R., Kupke, M., Broersen, A., Kitslaar, P.H., Massberg, S., Hadamitzky, M., Hausleiter, J.

“…To investigate the incremental prognostic value of low-attenuation plaque volume (LAPV) from coronary CT angiography datasets. Quantification of LAPV was…”
Get full text

Integrin ß1 polymorphisms and bleeding risk after coronary artery stenting by Thienel, M., Lüsebrink, E., Kastrati, A., Dannenberg, L., Polzin, A., Schulz, C., Massberg, S., Petzold, T.

“…Bleeding complications following percutaneous coronary intervention associate with increased mortality. However, the underlying molecular mechanisms are…”
Get full text

Retrospective analysis of circulatory support with the Impella CP ® device in patients with therapy refractory cardiogenic shock by Lackermair, K, Sattler, S, Huber, B.C, Grabmaier, U, Weckbach, L.T, Bauer, A, Theiss, H.D, Hausleiter, J, Mehilli, J, Massberg, S, Brunner, S

“…Abstract Background In cardiogenic shock (CS) the Impella CP ® device provides a fast available left ventricular circulatory support of up to 4.0 L/min…”
Get full text

Established interventions for mitral valve regurgitation: Current evidence by Orban, Mathias, Braun, D., Orban, Martin, Gross, L., Näbauer, M., Hagl, C.M., Massberg, S., Hausleiter, J.

“…Severe mitral regurgitation (MR) is a growing medical challenge in today’s aging population, leading to increased health expenditure due to the resultant…”
Get full text

Extracorporal life support (ECLS) in acute ischaemic cardiogenic shock by Sattler, S, Khaladj, N, Zaruba, M-M, Fischer, M, Hausleiter, J, Mehilli, J, Kääb, S, Hagl, C, Massberg, S, Theiss, H D

Get more information

A single German center experience with intermittent inotropes for patients on the high-urgent heart transplant waiting list by Hübner, T., Nickel, T., Steinbeck, G., Massberg, S., Schramm, R., Reichart, B., Hagl, C., Kiwi, A., Weis, Michael

“…Aim Currently, more than 900 patients with end-stage heart failure are listed for heart transplantation in Germany. All patients on the Eurotransplant…”
Get full text

The impact of smoking on the antiplatelet action of clopidogrel in non‐ST‐elevation myocardial infarction patients: results from the ISAR‐REACT 4 platelet substudy by SIBBING, D., BERNLOCHNER, I., SCHULZ, S., MASSBERG, S., SCHÖMIG, A., MEHILLI, J., KASTRATI, A.

Get full text